MEDISCA News at Your Fingertips

MEDISCA receives official rating as “Compliant” by Health Canada and offers solutions to Canadian drug shortage.

MEDISCA celebrates its 30th anniversary as a full-service supplier for the pharmaceutical compounding industry.

MEDISCA, the industry leader in providing high quality compounding solutions and services to healthcare professionals worldwide, was granted US patent No. 10,231,903 for planetary mixers. As of March 19, 2019, MEDISCA has exclusivity around the use of melting in planetary mixing machines with additional patents pending.

MEDISCA and their affiliates, LP3 Network and MEDISCA Network, continue their pursuit to increase awareness through the Student Pharmacist Compounding Competition (SPCC), with an unparalleled dedication to promote quality pharmaceutical compounding and contribute to the bright futures of students striving to meet the ever-growing needs of the patient population.

Today MEDISCA, the industry leader for providing high quality compounding solutions and services to pharmacists worldwide, announced that its Irving, Texas repackaging and distribution center received zero observations during its November 2018 current Good Manufacturing Practices (cGMP) inspection. The completion of this successful 10-day audit demonstrates the global company’s commitment to quality, safety, and patient care.

MEDISCA, a global leader in the pharmaceutical compounding industry, strives to proactively strengthen their quality systems and adhering to regulatory requirements and enforcement. MEDISCA is a company with a global presence and operates facilities in several countries while complying with the different regulations. Our internal policies and procedures are created and implemented throughout our organization as a global standard encompassing the industry’s regulatory requirements.